EUVIMEDSkopri EUVIMED
Crossref

Triptonide alleviates sepsis‐associated acute lung injury by suppressing the STAT3/HIF‐1α‐mediated aerobic glycolysis in macrophages

Triptonid lindert sepsisassoziierte akute Lungenschädigung durch Hemmung der STAT3/HIF-1α-vermittelten aeroben Glykolyse in Makrophagen

Junjie Zhu iD, Zhuoyao Ou iD, Haochen Ma iD, Qiang Huang iD, Linmin Pan iD, Huating Xie iD, Guoquan Pan iD, Shengwei Jin iD

British Journal of Pharmacology · 2026-11-06

DOI: 10.1111/bph.70725 ↗

Auf einen Blick

In Maus- und Zellmodellen verringerte Triptonid die Entzündung und die Pathologie einer sepsisassoziierten akuten Lungenschädigung. Der Effekt hing mit gehemmer STAT3/HIF-1α-Signalisierung und aerober Glykolyse zusammen.

Fragestellung

Welche therapeutische Wirkung und welcher Mechanismus von Triptonid bestehen bei sepsisassoziierter akuter Lungenschädigung?

Methode

LPS-induziertes Endotoxämie-Modell oder CLP-Modell bei Mäusen; zusätzlich LPS-behandelte primäre Mausmakrophagen in vitro, Transkriptomik, Aktivatoren/Inhibitoren und AAV-Genzielung.

Ergebnisse

Triptonid hemmte die proinflammatorische Aktivierung von Makrophagen, reduzierte pulmonale Entzündung, Infiltration, Ödem und Apoptose und verbesserte das Überleben septischer Mäuse. Der Effekt wurde bei myeloidem HIF-1α-Überexpressionsmodell aufgehoben.

Schlussfolgerung der Autor:innen

Triptonid schützt vor SA-ALI durch Hemmung der STAT3/HIF-1α-Signalkaskade und der aeroben Glykolyse-vermittelten proinflammatorischen Makrophagenaktivierung; es wird als potenzielle Therapie für SA-ALI beschrieben.

Kernaussagen

  • Triptonid reduzierte Entzündung und Lungenschädigung in Mausmodellen
  • Mechanismus: Hemmung von STAT3/HIF-1α und aerober Glykolyse
  • Bei HIF-1α-Überexpression war der therapeutische Effekt aufgehoben

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Journal article in British Journal of Pharmacology, published online on 2026-11-06. Written by Junjie Zhu and 7 co-authors. Institution: Department of Anesthesia and Critical Care, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhe…. 55 references. Funded by: National Natural Science Foundation of China, National Natural Science Foundation of China Joint Fund Project, Summit Advancement Disciplines of Zhejiang Province (Wenzhou Medical University - Pharmaceutics).

Auf einen BlickAstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background and Purpose Sepsis‐associated acute lung injury (SA‐ALI), represents a major contributor to mortality among septic patients during the early hyperinflammatory phase. Triptonide, a diterpenoids extract from Tripterygium wilfordii Hook f has anticancer and contraceptive effects. However, its potential and mechanism in SA‐ALI are largely unknown. This study aims to evaluate the therapeutic efficacy and elucidate underlying mechanisms of triptonide in SA‐ALI to identify new clinical strategies. Experimental Approach Lipopolysaccharide (LPS)‐induced endotoxemia model or caecal ligation and puncture (CLP) model was used to induce SA‐ALI in mice, accompanied by treatment with triptonide, triptolide and 2‐methoxyestradiol. Parallel in vitro experiments involved LPS‐treated mouse primary macrophages cultured with or without triptonide. Transcriptomic sequencing of macrophages was performed to explore the anti‐inflammatory mechanisms of triptonide, which were further substantiated using specific activators, inhibitors and adeno‐associated virus (AAV)‐mediated gene targeting. Key Results Our data shows that triptonide effectively inhibits macrophage pro‐inflammatory activation, reduces pulmonary inflammation and alleviates SA‐ALI pathology (i.e. inflammatory cell infiltration, oedema and cell apoptosis), thereby improving the survival of septic mice. Transcriptomic sequencing combined with metabolic analysis shows that triptonide suppresses aerobic glycolysis in pro‐inflammatory macrophages by inhibiting the Signal Transducer and Activator of Transcription 3 (STAT3)/Hypoxia inducible factor‐1α (HIF‐1α) axis. Notably, the therapeutic efficacy of triptonide against SA‐ALI was abolished in myeloid cell‐specific HIF‐1α overexpressed mice (LyzM‐Cre DIO‐ hif1a mice). Conclusions and Implications Triptonide protects against SA‐ALI by suppressing the STAT3/HIF‐1α signalling axis, thereby inhibiting aerobic glycolysis‐mediated pro‐inflammatory macrophage activation, which suggests that triptonide is a promising therapeutic strategy for SA‐ALI.

Subjects

Author keywords

STAT3Triptonideaerobic glycolysisinflammationsepsis‐associated acute lung injury

Authors and institutions

  • Department of Anesthesia and Critical Care, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Key Laboratory of Pediatric Anesthesiology, Ministry of Education, Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Precision Anesthesiology Key Laboratory of Zhejiang Province, Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Department of Anesthesiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.

ORCID profiles: Junjie Zhu, Zhuoyao Ou, Haochen Ma, Qiang Huang, Linmin Pan, Huating Xie, Guoquan Pan, Shengwei Jin

Funding

  • National Natural Science Foundation of China
  • National Natural Science Foundation of China Joint Fund Project
  • Summit Advancement Disciplines of Zhejiang Province (Wenzhou Medical University - Pharmaceutics)
  • Zhejiang Province's 'Jianbing Leading Goose +X' R & D Plan

Cite

APA

Zhu, J., Ou, Z., Ma, H., Huang, Q., Pan, L., Xie, H., Pan, G., & Jin, S. (2026). Triptonide alleviates sepsis‐associated acute lung injury by suppressing the STAT3/HIF‐1α‐mediated aerobic glycolysis in macrophages. British Journal of Pharmacology. https://doi.org/10.1111/bph.70725

Vancouver

Zhu J, Ou Z, Ma H, Huang Q, Pan L, Xie H, et al. Triptonide alleviates sepsis‐associated acute lung injury by suppressing the STAT3/HIF‐1α‐mediated aerobic glycolysis in macrophages. British Journal of Pharmacology. 2026. doi:10.1111/bph.70725

BibTeX
@article{Zhu2026,
  author = {Zhu, Junjie and Ou, Zhuoyao and Ma, Haochen and Huang, Qiang and Pan, Linmin and Xie, Huating and Pan, Guoquan and Jin, Shengwei},
  title = {Triptonide alleviates sepsis‐associated acute lung injury by suppressing the STAT3/HIF‐1α‐mediated aerobic glycolysis in macrophages},
  journal = {British Journal of Pharmacology},
  year = {2026},
  doi = {10.1111/bph.70725}
}
Start for free →